Telehealth on the rise, page-191

Depends upon what many people are expecting. If good news, I expect it will be a bump to 45c and then will settle back to 38c pre FDA (pre escrow release) as traders take profit. Then a brief pause before people wake up to the idea that if the news is good, FDA is a shoe-in and the escrow factor may get less regard (ie less concern of a sell-off because 1. the escrow holders might be circumspect about letting them go at a bargain price and 2. there will be sufficient demand in this scenario (a sell-off into good news) to absorb a dump so the price will temporarily flatten/dip to 33-35c while CT et al gobble up the cheap offerings). Then the price will gradually climb to around 65c in anticipation of FDA approval, building into the share price a higher base from which to rise after FDA approval. So, all IMO, a bit of a rollercoaster ride to 31 July with a nice view at the end. I hold but none of this is of any consequence to me. Even the post FDA surge that is highly likely doesn't matter: it's the revenue/dividends I'm after (although I understand they may not eventuate if RAP gets bought out). If that happens, I can still look forward to a decent takeover price in the ballpark of what ClownTrader was talking about a few posts above.

If I can get a few more in the meantime at current prices, all the better.

GLTAH and non-H